Goldberg B, Ackerman M
mBio. 2024; 16(1):e0190024.
PMID: 39660921
PMC: 11708040.
DOI: 10.1128/mbio.01900-24.
Mujic Franic A, Lilic M, Katalinic N, Glavas-Obrovac L
Int J Mol Sci. 2024; 25(22).
PMID: 39596170
PMC: 11593988.
DOI: 10.3390/ijms252212103.
Calvert R, Nyamboya R, Beavil A, Sutton B
Front Immunol. 2024; 15:1389494.
PMID: 39445016
PMC: 11496790.
DOI: 10.3389/fimmu.2024.1389494.
Frischauf N, Strasser J, Borg E, Labrijn A, Beurskens F, Preiner J
Proc Natl Acad Sci U S A. 2024; 121(44):e2406192121.
PMID: 39436656
PMC: 11536094.
DOI: 10.1073/pnas.2406192121.
Whitehead C, Wines B, Davies A, McDonnell J, Trist H, Esparon S
Immunol Rev. 2024; 328(1):438-455.
PMID: 39364646
PMC: 11659935.
DOI: 10.1111/imr.13400.
Therapeutic antibodies in oncology: an immunopharmacological overview.
Toledo-Stuardo K, Ribeiro C, Gonzalez-Herrera F, Matthies D, Le Roy M, Dietz-Vargas C
Cancer Immunol Immunother. 2024; 73(12):242.
PMID: 39358613
PMC: 11448508.
DOI: 10.1007/s00262-024-03814-2.
Enhancing Fc-mediated effector functions of monoclonal antibodies: The example of HexaBodies.
van der Horst H, Mutis T
Immunol Rev. 2024; 328(1):456-465.
PMID: 39275983
PMC: 11659923.
DOI: 10.1111/imr.13394.
Towards a unifying model for B-cell receptor triggering.
Degn S, Tolar P
Nat Rev Immunol. 2024; 25(2):77-91.
PMID: 39256626
DOI: 10.1038/s41577-024-01073-x.
Structural basis for surface activation of the classical complement cascade by the short pentraxin C-reactive protein.
Noone D, Isendoorn M, Hamers S, Keizer M, Wulffele J, van der Velden T
Proc Natl Acad Sci U S A. 2024; 121(37):e2404542121.
PMID: 39240968
PMC: 11406272.
DOI: 10.1073/pnas.2404542121.
Selection and characterization of a peptide-based complement modulator targeting C1 of the innate immune system.
Hamers S, Abendstein L, Boyle A, Jongkees S, Sharp T
RSC Chem Biol. 2024; 5(8):787-799.
PMID: 39092440
PMC: 11289891.
DOI: 10.1039/d4cb00081a.
The Crystal Structure of the Michaelis-Menten Complex of C1 Esterase Inhibitor and C1s Reveals Novel Insights into Complement Regulation.
Garrigues R, Garrison M, Garcia B
J Immunol. 2024; 213(5):718-729.
PMID: 38995166
PMC: 11333171.
DOI: 10.4049/jimmunol.2400194.
Neutralizing the threat: harnessing broadly neutralizing antibodies against HIV-1 for treatment and prevention.
Becerra J, Hitchcock L, Vu K, Gach J
Microb Cell. 2024; 11:207-220.
PMID: 38975023
PMC: 11224682.
DOI: 10.15698/mic2024.07.826.
Engineering Agonistic Bispecifics to Investigate the Influence of Distance on Surface-Mediated Complement Activation.
Hamers S, Boyle A, Sharp T
J Immunol. 2024; 213(2):235-243.
PMID: 38819221
PMC: 11215631.
DOI: 10.4049/jimmunol.2400091.
DNA Nanostructure-Templated Antibody Complexes Provide Insights into the Geometric Requirements of Human Complement Cascade Activation.
Abendstein L, Noteborn W, Veenman L, Dijkstra D, van de Bovenkamp F, Trouw L
J Am Chem Soc. 2024; 146(19):13455-13466.
PMID: 38703132
PMC: 11099972.
DOI: 10.1021/jacs.4c02772.
Crystal structure of calreticulin and the structural basis of its complement evasion mechanism involving C1q.
Jia Z, Yu W, Li J, Zhang M, Zhan B, Yan L
Front Immunol. 2024; 15:1404752.
PMID: 38690267
PMC: 11059001.
DOI: 10.3389/fimmu.2024.1404752.
Impact of structural modifications of IgG antibodies on effector functions.
Damelang T, Brinkhaus M, van Osch T, Schuurman J, Labrijn A, Rispens T
Front Immunol. 2024; 14:1304365.
PMID: 38259472
PMC: 10800522.
DOI: 10.3389/fimmu.2023.1304365.
Marked enhancement of the immunogenicity of plant-expressed IgG-Fc fusion proteins by inclusion of cholera toxin non-toxic B subunit within the single polypeptide.
Kim M, Vergara E, Tran A, Paul M, Kwon T, Ma J
Plant Biotechnol J. 2024; 22(5):1402-1416.
PMID: 38163285
PMC: 11022806.
DOI: 10.1111/pbi.14275.
Human anti-C1q autoantibodies bind specifically to solid-phase C1q and enhance phagocytosis but not complement activation.
Dijkstra D, van de Bovenkamp F, Abendstein L, Zuijderduijn R, Pool J, Kramer C
Proc Natl Acad Sci U S A. 2023; 120(50):e2310666120.
PMID: 38048459
PMC: 10723154.
DOI: 10.1073/pnas.2310666120.
Complement in Human Brain Health: Potential of Dietary Food in Relation to Neurodegenerative Diseases.
Xing Y, Zhang D, Fang L, Wang J, Liu C, Wu D
Foods. 2023; 12(19).
PMID: 37835232
PMC: 10572247.
DOI: 10.3390/foods12193580.
Profiling the Biophysical Developability Properties of Common IgG1 Fc Effector Silencing Variants.
Pejchal R, Cooper A, Brown M, Vasquez M, Krauland E
Antibodies (Basel). 2023; 12(3).
PMID: 37753968
PMC: 10526015.
DOI: 10.3390/antib12030054.